- Home
- TRVI vs MLAB Comparison
TRVI vs MLAB Comparison
Compare TRVI & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- MLAB
- Stock Information
- Founded
- TRVI 2011
- MLAB 1982
- Country
- TRVI United States
- MLAB United States
- Employees
- TRVI N/A
- MLAB N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- MLAB Industrial Machinery/Components
- Sector
- TRVI Health Care
- MLAB Industrials
- Exchange
- TRVI Nasdaq
- MLAB Nasdaq
- Market Cap
- TRVI 629.8M
- MLAB 680.0M
- IPO Year
- TRVI 2019
- MLAB N/A
- Fundamental
- Price
- TRVI $5.83
- MLAB $99.68
- Analyst Decision
- TRVI Strong Buy
- MLAB Hold
- Analyst Count
- TRVI 8
- MLAB 2
- Target Price
- TRVI $19.31
- MLAB $130.00
- AVG Volume (30 Days)
- TRVI 1.0M
- MLAB 40.8K
- Earning Date
- TRVI 05-08-2025
- MLAB 05-28-2025
- Dividend Yield
- TRVI N/A
- MLAB 0.64%
- EPS Growth
- TRVI N/A
- MLAB N/A
- EPS
- TRVI N/A
- MLAB N/A
- Revenue
- TRVI N/A
- MLAB $240,978,000.00
- Revenue This Year
- TRVI N/A
- MLAB $6.63
- Revenue Next Year
- TRVI N/A
- MLAB $5.61
- P/E Ratio
- TRVI N/A
- MLAB N/A
- Revenue Growth
- TRVI N/A
- MLAB 11.47
- 52 Week Low
- TRVI $2.30
- MLAB $83.68
- 52 Week High
- TRVI $7.39
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- TRVI 56.14
- MLAB 32.54
- Support Level
- TRVI $6.08
- MLAB $100.44
- Resistance Level
- TRVI $6.47
- MLAB $115.35
- Average True Range (ATR)
- TRVI 0.39
- MLAB 5.19
- MACD
- TRVI -0.00
- MLAB -2.03
- Stochastic Oscillator
- TRVI 45.06
- MLAB 8.53
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.